Anticancer Bioscience logo

Anticancer Bioscience

Applying our synthetic lethality expertise for better cancer therapies

17 employees · est. 2016 · Chengdu, China

VS
Athenex logo

Athenex

89 employees · est. 2003 · Buffalo, United States

Athenex is the older company (2016 vs 2003); Athenex is the larger of the two.

Side-by-Side Comparison

Anticancer Bioscience Athenex
Founded
2016 2003 older
Headquarters
Chengdu, China Buffalo, United States
Employees
17 89 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Seed Post Ipo Equity
Total Funding
$200.15M $342.15M
Funding Rounds
3 10
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Therapeutics, Synthetic Lethal Therapies, Oncology Research, Cancer Vulnerabilities, Genetic Perturbations, Medicinal Chemistry, Drug Development, Targeted Therapies, Cancer Treatment Innovation, Global Research And Development, Employment Opportunities, Equal Opportunity Employer Oncology Pharmaceutical, Cancer Therapies, Innovation, Manufacturing Supply Chain, Global, Specialty Pharmaceuticals, Drug Development, Life-changing Impact, China, North America, Proprietary Medical Technology, Regulatory Environments, Connected Innovation, Global Presence
Website
anticancerbio.com athenex.com
Anticancer Bioscience logo

About Anticancer Bioscience

Anticancer Bioscience (ACB) is a precision therapeutics company headquartered in Chengdu, China, with global research and development teams in India, the United Kingdom, and the United States. The company's focus lies in developing synthetic lethal therapies that address unmet medical needs in the f...

Athenex logo

About Athenex

Athenex is a global specialty oncology pharmaceutical company founded in 2003 and headquartered in the United States. The company is dedicated to the development and commercialization of next generation therapies for cancer diseases and supportive therapies. With a focus on delivering innovative dru...

We will tell you when either one moves

BounceWatch watches Anticancer Bioscience and Athenex for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Anticancer Bioscience and Athenex — by email.

Frequently Asked Questions

Anticancer Bioscience — Applying our synthetic lethality expertise for better cancer therapies. Athenex. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Anticancer Bioscience has raised $200.15M while Athenex has raised $342.15M.
Anticancer Bioscience and Athenex operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Anticancer Bioscience with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Anticancer Bioscience on 12 Sep 2024, and Athenex on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy